RE:Special Meeting Content Well there you have it. Andrew Schutte will increase his stake in replicel from 15.39% to 22.30%.
At first glance the biggest question is why is he wanting such a large stake in the company ?
It stinks to high heaven that Directors and insiders know what is happening with the Shiseido Arbitration and most likely know what is happening with the Dermal Injector but we don't. If this is the case they are withholding key information from the shareholders.
I guess the only silver lining that can be derived here is instead of him dumping stock he is buying stock at this critical time.